September 3, 2019
NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark  this link  for your convenience.

The month of September is
Gynecologic Cancer Awareness Month & Prostate Cancer Awareness Month.

 

ACTIVATIONS
LUNG

NRG-LU005: Canadian Sites Only – This protocol has been approved by Health Canada. The NOL and documents for review and completion are posted on the CTSU website.

 

FORM UPDATES

LUNG

NRG-LU002: A new question has been added to the Work Up form in the Baseline folder of Rave for all patients. This may cause the form to appear overdue for your existing patients. Please provide a response to the new question and save the form again as soon as possible to avoid any potential overdue issues.

 

NRG-LU005: Revised Quality of Life forms have been posted on CTSU. Correct QOL forms can be accessed at these locations: 

  • NRG-LU005 > CIRB Documents > Amendment Reviews > Participant Questionnaire > Support Documents # 1-6 posted 8/9/2019
  • NRG-LU005 > CIRB Documents > Amendment Reviews > Participant Questionnaire > Support Documents #1-4 posted 6/10/2019
  • NRG-LU005 > CIRB Documents > Initial Reviews > Support Documents #12-13 posted 5/28/2019
OTHER PROTOCOL NOTICES

1. BREAST

NRG-BR004: A memo regarding the posting of slides from the NRG Oncology meeting has been posted on the CTSU website.

 

NRG-BR004: A memo regarding Access to the Bioclinica Web Portal has been posted on the CTSU website.

NSABP B-51: E-mail Blast (posted to CTSU)


2. GYNECOLOGIC

NRG-GY005: CEC Whole Blood Shipping Address memo (posted to CTSU)

 

NRG-GY007: Please be advised that the drug request form has been updated to reflect a new lot number (266543). Please disregard previous versions and utilize the new form for all future requests. (posted on NRG Oncology)

 

NRG-GY009: Block Submission Reminder memo (posted to CTSU)

 

NRG-GY018: Kit Ordering memo (posted to CTSU)

 

NRG-GY018: The IND # is 140014. The NCT # is 03914612. These will be added to the title page with the next amendment.

 

Form TR for Biospecimens Shipped to NRG Biospecimen Bank-Columbus Read more

 

Biospecimen Bank-Columbus & SDMC Undergoing Refurbishment Read more


3. LUNG

NRG-LU005:  Information regarding Site Initiation Training is located in section 13.3 of the protocol posted on the CTSU website.  An amendment is planned that will include updates to section 8 to clarify that Site Initiation Training is required for all sites throughout the U.S. and Canada. 

 

4. VTOC TRAINING

The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001, NRG-HN002, NRG-CC003, and NRG-CC004. Space is limited so register now and reserve your seat. The next webinar training is scheduled for Wednesday, September 11.

 

 

DRUG SAFETY UPDATES

Safety updates have been issued for the following studies:

DRUG NAME

PROTOCOL

WEBSITE FOR SAFETY REPORTS

Ipilimumab

NRG-BN002

NRG

Nivolumab

NRG-BN002

NRG

Pembrolizumab

NRG-GI002

NRG-HN003

NRG-GY016

NRG-GY018

CTSU

NRG

CTSU

CTSU

CTN/CRA Workshop Roundtable Educational Session at #NRG19

Additional handouts from the CTN/CRA Workshop Roundtable Educational Session and a revised slide set for the Research Misconduct lecture held during the July 2019 NRG Oncology Meeting have been posted to the Nurses and CRA/Education and Training page on the NRG Oncology website (login required).

NRG Oncology is pleased to report the scientific articles and abstracts that have appeared or have been presented during the previous week. This publications report includes links, when available, to the article, PubMed abstract, or association abstract.

JOURNAL ARTICLES

Eldridge RC, Pugh SL, Trotti A, Hu K, Spencer S, Yom S, Rosenthal D, Read N, Desai A, Gore E, Shenouda G, Mishra MV, Bruner D, Xiao C. Changing functional status within 6 months post-treatment is prognostic of overall survival in patients with head and neck cancer: NRG Oncology Study. Head Neck. 2019 Aug 22. doi: 10.1002/hed.25922. [Epub ahead of print] PubMed PMID: 31435980. Read More

Swain SM, Tang G, Lucas PC, Robidoux A, Goerlitz D, Harris BT, Bandos H, Geyer CE Jr, Rastogi P, Mamounas EP, Wolmark N. Pathologic complete response and outcomes by intrinsic subtypes in NSABP B-41, a randomized neoadjuvant trial of chemotherapy with trastuzumab, lapatinib, or the combination. Breast Cancer Res Treat. 2019 Aug 19. doi: 10.1007/s10549-019-05398-3. [Epub ahead of print] PubMed PMID: 31428908. Read More


PUBLICATIONS REMINDERS

Please note the following upcoming meeting and abstract submission deadline dates

Upcoming Meetings

American Society for Radiation Oncology (ASTRO); Sep 15-18, 2019 ; Chicago, IL

European Society for Medical Oncology (ESMO); Sep 27-Oct 1, 2019; Barcelona, Spain

International Gynecologic Cancer Society (IGCS); Sep 19-20, 2019; Rio de Janeiro, Brazil

 

International Society for Quality of Life Research (ISOQOL); Oct 20-23, 2019; San Diego, CA


Upcoming Abstract Submission Deadlines

American Association for Thoracic Surgery (AATS); Apr 25-28, 2020; New York, NY; due to publications committee Oct 1, 2019; meeting submission deadline Oct 15, 2019

American Society of Clinical Oncology (ASCO) GI; Jan 23-25, 2020; San Francisco, CA; due to publications committee Sep 17, 2019; meeting submission deadline Oct 1, 2019

American Society of Clinical Oncology (ASCO) GU; Feb 13-15, 2020; San Francisco, CA; due to publications committee Oct 8, 2019; meeting submission deadline Oct 22, 2019

Society of Gynecologic Oncology (SGO); Mar 28-31, 2020; Toronto, ON Canada; due to publications committee Sep 3, 2019; meeting submission deadline Sep 17, 2019; Intl abstr  11-5-19; LBA 1-7-20

Society of Surgical Oncology (SSO); Mar 25-28, 2020; Boston, MA; due to publications committee Sep 16, 2019; meeting submission deadline Oct 7, 2019

 

NRG Oncology is proud to be an active participant of #CancerMoonShot.
This message was sent from NRG-Broadcasts@NRGOncology.org to NRG-Broadcasts@NRGOncology.org
Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103


Update Profile/Email Address | Forward Email | Report Abuse